Skip to main content
OCS logo
OCS
(NASDAQ)
Oculis Holding AG
$27.91-- (--)
Loading... - Market loading

Oculis Holding (OCS) Stock Price & Financial Analysis

Oculis Holding Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$27.35 - $28.25
52-Week High$34.48
52-Week Low$16.00
Open$27.89
Volume407.25K
Average Volume (3M)420.02K
Market Cap1.46B
Shares Outstanding52.36M
Price to Sales (P/S)1460.52
Price to Book (P/B)5.87
EV/EBITDA-13.77
Revenue (TTM)1.00M
Net Income (TTM)-125.49M
Free Cash Flow (TTM)-85.11M
EPS (TTM)$-2.40
Profit Margin-12519.43%
Operating Margin-10383.03%
Return on Equity (ROE)-50.32%
Debt to Equity0.01
50-Day MA$27.21
200-Day MA$22.56
52-Week Change85.51%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Oculis Holding

What is the current stock price for OCS?

As of the latest trading session, OCS stock trades at $27.91. The 52-week range is $16.00–$34.48, with a day range of $27.35–$28.25.

What is the P/E ratio for OCS?

The P/E ratio (Price-to-Earnings) for OCS is shown in the Key Statistics section. This valuation metric helps compare Oculis Holding AG to industry peers.

Does OCS pay dividends?

Oculis Holding does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for OCS?

Based on 3 analysts, the consensus for OCS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of OCS?

Oculis Holding's market capitalization is $1.46B, classifying it as a small-cap company. Oculis Holding operates in the Healthcare sector within the Biotechnology industry.